Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of Speeda® Rabies Vaccine for Human Use

NCT01821911 is registered in ClinicalTrials.gov with Beijing Center for Disease Control and Prevention as lead sponsor.

NCT NCT01821911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01821911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of Speeda® Rabies Vaccine for Human Use
Lead sponsor
Beijing Center for Disease Control and Prevention
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2012
Completion date
December 31, 2014
Enrollment
10,500 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

anti-d antibodies, rabies vaccine allergy, vaccination adverse event